Seventy-eight cases of enterovirus infection, including 25 neuroinfections, occurred in Rostov-on-Don, Russia, during May–June 2013. The outbreak was caused by an enterovirus A type 71 (EV-A71) subgenotype C4 lineage that spread to neighboring countries from China ≈3 years earlier. Enterovirus associated neuroinfection may emerge in areas with a preceding background circulation of EV-A71 with apparently asymptomatic infection.
Enterovirus A type 71 (EV-A71; family
During 2013, an outbreak of EV-A71 infection occurred in Rostov-on-Don, a city in southern Russia. The first case was diagnosed on May 31 in a 2-year-old boy. A cerebrospinal fluid sample from the boy contained EV-A71 and pneumococcal bacteria, suggesting combined bacterial and viral meningoencephalitis. The boy died of meningoencephalitis on day 5 after disease onset. According to the official State Surveillance System report, 366 children (1–7 years of age) attended the same childcare facility as the boy who died, and over the 3 weeks after the index case, 77 more children were involved in the outbreak (
Incidence of neuroinfection during an enterovirus A type 71infection outbreak among children attending a childcare facility, Rostov-on-Don, Russia, 2013. Of 78 infected children (1–7 years of age), 25 experienced neuroinfection (meningitis or meningoencephalitis) and 53 experienced mild infection (hand, foot and mouth disease or fever).
Enterovirus RNA was detected in fecal samples (n = 53), throat swab samples (n = 23), or both (n = 17) from 59 of the 78 patients. EV-A71 was identified by partial viral protein 1 genome region sequencing in the cerebrospinal fluid sample from the first patient and in fecal and throat swab samples from the other patients. The outbreak was officially defined as including only those children from the childcare facility attended by the index patient. Additional cases of HFMD and meningitis that occurred outside that kindergarten were not officially accounted for in outbreak statistics; thus, it is likely that the outbreak size was underestimated. Simovanian et al. (
The ratio of neuroinfection (meningitis and meningoencephalitis) cases relative to mild infection (i.e., HFMD and fever) cases was unusually high in this outbreak. Among the 78 officially reported cases, 25 (32.1%) were meningitis or meningoencephalitis. After the first fatal case, all children in the childcare facility were proactively screened for enterovirus infection symptoms, so it is unlikely that many patients with mild infection were missed. Asymptomatic children were not screened for EV-A71 RNA. However, the ratio of meningitis cases was high even relative to the total number of children attending the childcare facility (6.8% [25/366 children]). This finding differs from those from a 1998 outbreak in Taiwan, in which 405 (0.3%) of 129,106 persons with HFMD had severe disease (i.e., fever >38°C or neurologic manifestations) (
Thirteen isolates from the EV-A71–infected children were available for study. Viruses were propagated in cell culture, and the entire viral protein 1 genome region (891 nt) was amplified as described previously (
Phylogenetic analysis of the virus spread was performed by using a Bayesian phylogenetic approach implemented in BEAST version 1.7.5 (
Phylogenetic tree comparing sequences of outbreak and other enterovirus A type 71 (EV-A71) subgenogroup C4 strains isolated in Russia during 2012–2013 with the most closely related sequences in GenBank. Complete viral protein 1 genome regions (891 nt) were compared. The tree was reconstructed by using a coalescent Bayesian algorithm implemented in BEAST 1.7.5 (
In the phylogenetic tree, isolates from Rostov-on-Don grouped (with a posterior probability of 1) with an additional 6 viruses that were isolated in the neighboring Stavropol region during and up to 2 months after the outbreak (
Over the past 2 decades, EV-A71 became a prominent emerging virus in Asia. However, the EV-A71 epidemiologic situation remained calm in Russia, Europe, and North America, despite common circulation of the virus, as suggested by surveillance and seroepidemiologic studies (
This study received core funding from the participating institutions and from a Russian scientific foundation grant (no. 14-15-00619 to A.N.L. and L.V.A.).
Dr. Akhmadishina is a postdoctoral researcher. In 2013 she completed a PhD thesis on molecular epidemiology and seroepidemiology of EV-A71 in Russia.